Compare HCA Health Inc (HCA) vs Manchester United PLC (MANU) Price & Performance

HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.

The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.

Manchester United (MANU) trades at $20.25, down 0.74% on the day, amid a bearish technical signal. The company reported a net loss of $33.02 million for 2025 despite revenue of $666.51 million, with negative profit margins and return metrics. Recent news highlights a valuation gap, with the market cap at $3.6 billion versus a Forbes estimate of $7.2 billion, while operational performance shows some improvement with a return to Champions League football.

The outlook remains cautious; while the valuation discount presents a potential opportunity, persistent losses and high debt levels pose significant risks. Analyst sentiment is mixed with a 40% buy rating, but fundamental challenges in achieving sustained profitability are key concerns for investors.